BLOOD TEST MAY HELP PREDICT RISK OF COGNITIVE DECLINE DUE TO ALZHEIMER'S A DECADE BEFORE SYMPTOMS APPEAR

Data Readoutpositivep-tau217 blood biomarker testPositive

AI Analysis

Summary

A blood test measuring p-tau217 levels may help predict Alzheimer's-related cognitive impairment risk up to a decade before symptoms appear, with very high levels associated with 78% risk of cognitive decline over 10 years.

Outcome Details

Blood test showed symptom-free older adults with very high levels of p-tau217 had an estimated 78% risk of developing cognitive impairment over 10 years

Importance:6/10

Sentiment:

0.65

Alzheimer's diseaseBlood biomarkerCognitive decline predictionDiagnostic testp-tau217

Read the original article

Published by PR Newswire Clinical Trials on July 15, 2026 4:01 AM

Read Original